CLB Core Laboratories Inc. /DE/
Oil & Gas Field Services, NEC · NYSE · SEC CIK 1958086 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.1%
TTM net income YoY-51.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR0.5%
Net income 3-yr CAGR-27.7%
Margins
Gross margin19.1%
Operating margin7.5%
Net margin3.0%
FCF margin2.0%
EBITDA margin10.4%
Returns
ROE5.7%
ROA2.6%
ROIC (approx.)6.0%
Asset turnover0.88x
Leverage & solvency
Liabilities / assets52.1%
Debt / equity0.40x
Current ratio2.19x
Interest coverage3.50x
Cash quality & payout
Operating cash flow / net income1.59x
Accruals ratio-1.5%
Payout ratio11.9%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $132.08M | $124.61M | $121.80M | $138.25M | $134.52M | $130.16M | $123.58M | $129.24M |
| Cost of revenue | $105.09M | $101.37M | $102.07M | $109.52M | $104.90M | $103.70M | $99.47M | $106.20M |
| Gross profit | $26.98M | $23.24M | $19.72M | $28.74M | $29.62M | $26.46M | $24.12M | $23.04M |
| SG&A expense | $11.27M | $10.95M | $14.72M | $10.63M | $10.69M | $10.46M | $13.65M | $9.08M |
| Operating income | $12.06M | $9.15M | $1.89M | $15.83M | $20.93M | $15.29M | $4.42M | $14.17M |
| Interest expense | $2.79M | $2.85M | $2.89M | $2.61M | $2.65M | $2.71M | $2.60M | $2.63M |
| Pretax income | $9.28M | $6.30M | -$1.00M | $13.22M | $18.28M | $12.58M | $1.81M | $11.54M |
| Income tax | $3.82M | $507,000 | -$251,000 | $8.09M | $3.75M | $1.91M | $1.75M | $4.08M |
| Net income | $5.44M | $5.96M | -$789,000 | $4.95M | $14.24M | $10.64M | -$154,000 | $7.40M |
| EBITDA | $15.79M | $12.98M | $5.65M | $19.50M | $24.52M | $18.96M | $8.13M | $17.84M |
| EPS (basic) | 0.12 | 0.13 | -0.02 | — | 0.31 | 0.23 | 0.00 | — |
| EPS (diluted) | 0.12 | 0.13 | -0.02 | — | 0.30 | 0.22 | 0.00 | — |
| Dividends declared per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted avg. shares (diluted) | 46.71M | 46.88M | 46.07M | — | 47.08M | 47.36M | 46.77M | — |
| Banking | ||||||||
| Provision for credit losses | $43,000 | -$149,000 | $241,000 | — | $549,000 | $935,000 | $668,000 | — |
| Balance sheet | ||||||||
| Cash & equivalents | $21.38M | $22.73M | $22.82M | $22.70M | $25.63M | $31.19M | $22.11M | $19.16M |
| Receivables | $115.57M | $108.82M | $108.28M | $113.53M | $110.26M | $113.91M | $117.03M | $111.76M |
| Inventory | $60.70M | $57.96M | $57.78M | $54.50M | $58.24M | $59.77M | $59.03M | $59.40M |
| Current assets | $225.06M | $214.36M | $214.37M | $214.66M | $226.91M | $237.68M | $228.77M | $221.33M |
| PP&E, net | $100.84M | $100.39M | $99.98M | $99.45M | $98.03M | $97.93M | $97.94M | $97.06M |
| Goodwill | $105.92M | $105.80M | $105.80M | $105.79M | $100.01M | $100.00M | $99.44M | $99.44M |
| Intangibles | $6.64M | $6.75M | $6.89M | $7.12M | $6.11M | $6.17M | $6.28M | $6.40M |
| Total assets | $593.52M | $586.78M | $587.73M | $584.01M | $586.08M | $596.84M | $586.24M | $585.13M |
| Current liabilities | $102.73M | $101.05M | $104.73M | $106.02M | $95.74M | $104.77M | $103.73M | $102.44M |
| Long-term debt | $112.45M | $113.86M | $114.46M | $110.25M | $114.10M | $124.61M | $124.37M | $126.11M |
| Total debt | $112.45M | $113.86M | $114.46M | $110.25M | $114.10M | $124.61M | $124.37M | $126.11M |
| Total liabilities | $309.43M | $308.01M | $312.58M | $311.80M | $319.39M | $340.23M | $337.58M | $332.81M |
| Shareholders' equity | $277.97M | $272.67M | $268.89M | $265.99M | $271.35M | $261.28M | $253.39M | $246.57M |
| Net debt | $91.07M | $91.13M | $91.64M | $87.55M | $88.47M | $93.42M | $102.26M | $106.95M |
| Shares outstanding | 45.81M | 45.88M | 46.05M | 46.10M | 46.09M | 46.54M | 46.70M | 46.83M |
| Cash flow statement | ||||||||
| Operating cash flow | $4.97M | $7.81M | $3.96M | $7.95M | $8.50M | $13.92M | $6.66M | $20.61M |
| Capital expenditure | $3.25M | $4.69M | $3.45M | $2.94M | $2.01M | $3.47M | $2.79M | $4.38M |
| Free cash flow | $1.72M | $3.12M | $517,000 | $5.00M | $6.50M | $10.45M | $3.88M | $16.23M |
| Investing cash flow | -$3.19M | -$3.93M | -$3.39M | -$3.75M | $2.39M | -$1.64M | $772,000 | -$3.56M |
| Financing cash flow | -$3.14M | -$3.96M | -$457,000 | -$7.12M | -$16.45M | -$3.20M | -$4.48M | -$19.37M |
| Depreciation & amortization | $3.72M | $3.83M | $3.76M | $3.67M | $3.59M | $3.67M | $3.72M | $3.66M |
| Stock-based compensation | $1.28M | $902,000 | $5.03M | $1.11M | $1.33M | $538,000 | $4.16M | -$458,000 |
| Dividends paid | $459,000 | $460,000 | $460,000 | $466,000 | $465,000 | $469,000 | $469,000 | $469,000 |
| Share buybacks | $1.05M | $2.69M | $4.00M | $2.66M | $5.01M | $2.74M | $2.02M | $4.90M |
Free plan shows the latest 8 periods; Pro shows all 19 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.